Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ro60 Expression in Macrophages in Patients with Primary Sjogren's Syndrome

NCT06324968 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT06324968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06324968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ro60 Expression in Macrophages in Patients with Primary Sjogren's Syndrome
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 9, 2024
Completion date
May 9, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sjogren's syndrome